Hemostats Market Size is expected to reach USD 4.5 billion by 2024 - PowerPoint PPT Presentation

About This Presentation
Title:

Hemostats Market Size is expected to reach USD 4.5 billion by 2024

Description:

Global Hemostats Market, By Product Type (Thrombin Based, Combination, Oxidized Regenerated Cellulose Based, Gelatin Based, Collagen Based Hemostat), By Indication (Wound Closure, Surgery), By End-User (Hospitals, Clinics, Ambulatory Centers, Community Healthcare, Others), By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Trends and Forecast to 2024 Read More: – PowerPoint PPT presentation

Number of Views:10

less

Transcript and Presenter's Notes

Title: Hemostats Market Size is expected to reach USD 4.5 billion by 2024


1
Hemostats Market Size 2017 Global Industry
Share, Growth, Outlook, Trends and Forecast to
2024
Global Hemostats Market, By Product Type
(Thrombin Based, Combination, Oxidized
Regenerated Cellulose Based, Gelatin Based,
Collagen Based Hemostat), By Indication (Wound
Closure, Surgery), By End-User (Hospitals,
Clinics, Ambulatory Centers, Community
Healthcare, Others), By Geography (North America,
South America, Europe, Asia-Pacific, Middle East
and Africa) Trends and Forecast to 2024
Browse Full Report and Details TOC
http//databridgemarketresearch.com/reports/global
-hemostats-market/
2
Report Description
The Global Hemostats Market is expected to reach
USD 4.5 billion by 2024 from USD 2.7 billion in
2016, at a CAGR of 6.6 in the forecast period
2017 to 2024. The major factors driving the
growth of this market are the increasing number
of surgeries, increasing healthcare expenditure,
technological advancements, chronic condition and
aging population. These factors increase the
demand of various hemostats agents. On the other
hand weak reimbursement and reluctance of
surgeons towards acceptance of new products may
hinder the growth of the market.
Request For Free Sample Report
http//databridgemarketresearch.com/request-a-sam
ple/?dbmrglobal-hemostats-market
3
Report Segmentation
The Global Hemostats Market is segmented on the
basis of type, application, distribution channel,
and end user. The global hemostats market is
segmented into 5 major types, namely thrombin
based hemostats, combination agents, oxidized
regenerated cellulose based haemostats, gelatin
based haemostats and collagen based haemostats.
On the basis of application, the market is
segmented into surgery and wound closure. On the
basis of end users, the market is classified into
hospitals, community healthcare, ambulatory
centres and clinics. In 2017, the hospital
segment is expected to dominate the market and is
expected to continue this trend till 2024.
Request for Customization _at_ sales_at_databridgemarke
tresearch.com
4
Key Drivers
  • Some of the major factors driving the market for
    hemostats market are increasing number of
    surgeries, technological advancement, increasing
    healthcare expenditure and infrastructure. These
    factors are increasing the demand for different
    heomostatic agents.
  • Reluctance of surgeons towards new products may
    hinder the growth of this market.
  • The weak reimbursement scenario will hamper the
    growth of the market for new and innovative
    therapies or hemostats products, causing
    companies to withdraw from the market thus
    increasing the hospital costs putting all burdens
    onto the patient for treatment.
  • Inquiry before buying
    http//databridgemarketresearch.com/inquire-before
    -buying/?dbmrglobal-hemostats-market

5
Key Points
  • Ethicon US LLC (U.S.) is dominating the
    hemostats market followed by Pfizer and C.R. Bard
    Inc., along with others such as Baxter, Vascular
    Solutions, Inc., B.Braun Melsungen, 3-D Matrix,
    Ltd., Resorba Medical GmbH (an Advanced Medical
    Solutions Group plc Company), Anika Therapeutics,
    Inc., Arch Therapeutics Inc., BiomUp SAS,
    CryoLife, Inc., Gamma Therapeutics, Inc.,
    Hemostasis, LLC, MedTrade Products Limited,
    Integra LifeSciences Corporation, Medline
    Industries, Inc., HEMOTEC MEDICAL GMBH, Stryker,
    CSL Behring, Mallinckrodt, and Equimedical, B.V.
    among other companies.
  • Combination agents market is growing with the
    highest CAGR.
  • Thrombin based hemostats is driving the market
    with the highest market share.
  • Surgery is dominating the application segment in
    the hemostats market.

6
About Data Bridge Market Research
An absolute way to forecast what future holds is
to comprehend the trend today! Data Bridge Market
Research set forth itself as an unconventional
and neoteric Market research and consulting firm
with unparalleled level of resilience and
integrated approaches. We are determined to
unearth  the best market opportunities and foster
efficient information for your business to thrive
in the market. Data Bridge endeavors to provide
appropriate solutions to the complex business
challenges and initiates an effortless
decision-making process. Read Continue
http//databridgemarketresearch.com/about-us/
Contact Us Ankit Singh1-888-387-2818 (Toll
Free) sales_at_databridgemarketresearch.com
Write a Comment
User Comments (0)
About PowerShow.com